Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

NCT00657813 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Data did not evidence \[123I\]MNI-330 as a useful tool in the detection of AD.

Conditions

Interventions

Sponsor

Institute for Neurodegenerative Disorders

Collaborators